ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 4 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $544,000 | -29.7% | 13,450 | 0.0% | 0.39% | -22.6% |
| Q2 2015 | $774,000 | -14.7% | 13,450 | -5.6% | 0.50% | -13.8% |
| Q1 2015 | $907,000 | +14.8% | 14,250 | +11.3% | 0.58% | +11.6% |
| Q4 2014 | $790,000 | +83.3% | 12,800 | +15.3% | 0.52% | +75.3% |
| Q3 2014 | $431,000 | +65.8% | 11,100 | +47.2% | 0.30% | +64.4% |
| Q2 2014 | $260,000 | – | 7,540 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |